3D Systems Corp (DDD) Securities Class Action Lawsuit Update [July 20, 2025]

Introduction to 3D Systems Corp (DDD) Securities Class Action Lawsuit

A securities fraud class action lawsuit has been filed against 3D Systems Corporation (NYSE: DDD) on behalf of investors who purchased the Company’s common stock between August 13, 2024, and May 12, 2025 (the “Class Period”). The lawsuit alleges 3D Systems and certain executives violated federal laws by overstating the Company’s resilience to market challenges and revenue from a key partnership. A milestone change and weak demand crushed earnings. Stocks tanked, costing investors millions. Shareholders are suing to recover losses. 

3D Systems Corp (DDD) Lawsuit Case Details  

Herbermann v. 3D Systems Corp., et al. 

Case No.: 1:25-cv-00734 

U.S. District Court, District of Delaware 

Filed on June 13, 2025 

 3D Systems Corp (DDD) Company Profile  

3D Systems (NYSE: DDD) provides 3D printing solutions globally. It operates two main segments: Healthcare and Industrial.  The company offers printers, materials, and services in both segments. The company’s Regenerative Medicine program, which is partnered with United Therapeutics Corporation, aims to 3D print human organs. 

Class Period:  

August 13, 2024 to May 12, 2025, inclusive 

Investors who purchased 3D Systems securities during the class period might be eligible to join the 3D Systems securities fraud class action lawsuit. 

Allegations in the 3D Systems Corp (DDD) Securities Class Action Lawsuit

Plaintiffs say 3D Systems and its executives (Jeffrey A. Graves and Jeffrey D. Creech) violated federal securities law, such as the Securities Exchange Act, by making false and misleading statements about the company’s revenue and its relationship with United Therapeutics. 

On August 13, 2024, 3D Systems released its Form 10-K in which the company claimed strong growth in healthcare and industrial markets.  In August 2024, it also issued a press release announcing its quarterly financial results.  The August 2024 release andassociated earnings call maintained the same strong story.  The Company touted 10% revenue growth and a dental contract worth $250 million.  The growth narrative persisted into March 2025, when the Company projected its 2025 revenue between and improved EBITDA.  

But the numbers didn’t add up. The complaint says 3D Systems hid weakened customer spending and a change in its United Therapeutics partnership, both hurting Regenerative Medicine revenue.   

The filed complaint alleges 3D Systems’ failure to disclose these risks violated federal securities laws, including Sections 10(b) and 20(a) of the Securities Exchange Act. Plaintiffs’ legal claims state 3D Systems’ statements about its resilience and revenue were materially false and misleading, lacked a reasonable basis, and adversely affected investors. 

The Truth Emerges  

On March 26, 2025, 3D Systems issued its Q4 2024 earnings press release.  The company reported lackluster revenue figures, as quarterly revenue was down 3.4%, missing estimates by $4.17 million. The company also disclosed updated milestone critunder its Regenerative Medicine partnership with United Therapeutics.  This change significantly reduced expected revenue from Regenerative Medicine and weakened the program’s financial outlook.  

On May 12, 2025, 3D Systems released its Q1 2025 financial results.  Those results were also dismal.  Revenue was down 8%, reflecting a $37 million loss – twice as much as the same quarter in 2024.  The Company withdrew 2025 guidance, citing weak demand and dental inventory issues.  

Market Reaction 

Investors reacted negatively to 3D Systems’ continued misses. On March 27, 2025, 3D Systems’ stock fell 20.96%, from $2.72 to $2.15, costing investors millions.  The May results caused another tumble, deepening investor losses.  

 Next Steps  

• Submissions for lead plaintiff are due August 12, 2025.  

• The Court will issue its order for lead plaintiff and counsel in the weeks after submissions are due.    

• The Court will then consider motion for class certification.     

• The Court will later consider a Motion to Dismiss.    

To learn if you are eligible for recovery under the 3D Systems securities class action lawsuit, visit the case submission page here.

Disclaimer: This shareholder alert is for informational purposes only and does not constitute legal advice. Consult a qualified attorney for personalized guidance. No specific outcomes are guaranteed.